Project Name: Cysteine ​​tartrate controlled release capsules

 

Composition: cysteamine tartrate, ammonium hydroxide, black iron oxide, colloidal silicon dioxide, croscarmellose sodium, gelatin, magnesium stearate, microcrystalline cellulose, pharmaceutical glaze, pregelatinized starch, propylene glycol , silicon dioxide, sodium lauryl sulfate, and titanium dioxide.

 

Dosage Form: controlled release capsules

Specifications: 50mg, 150mg

Indications: for the treatment of children and adults with kidney disease type cystinosis.

 

The project is declared as a 3.1 class of drugs, the company has achieved cysteamine tartrate 100 kg production scale. For specific project description please contact us.